Moderna, the small biotech company taking on the pandemic

Washington (AFP) – Moderna has long been a darling of investors but it wasn’t until the coronavirus pandemic came along that the Cambridge, Massachusetts-based biotech company could prove the value of its new vaccine technology and mint some new billionaires.Moderna announced on Monday that its experimental vaccine against the coronavirus was 94.5 percent effective, about the same efficacy as the common vaccine against measles.The announcement sent the share price of the company founded just a decade ago soaring on the NASDAQ in New York. Since January, Moderna has seen its share price quintup…

Read More

HEDGE accordingly